Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies
ContributorsLauper, Kim
; Mongin, Denis
; Bergstra, Sytske Anne
; Choquette, Denis; Codreanu, Catalin; Gottenberg, Jacques-Eric; Kubo, Satoshi
; Hetland, Merete Lund
; Iannone, Florenzo; Kristianslund, Eirik K.
; Kvien, Tore K.; Lukina, Galina
; Mariette, Xavier; Nordström, Dan C.; Pavelka, Karel; Pombo-Suarez, Manuel; Rotar, Ziga; Santos, Maria J.
; Tanaka, Yoshiya
; Turesson, Carl
; Courvoisier, Delphine
; Finckh, Axel
; Gabay, Cem
Published inJoint bone spine, vol. 91, no. 2, 105671
Publication date2024-03
First online date2023-11-30
Abstract
Keywords
- Biologic
- Corticosteroid
- Epidemiology
- IL-6 inhibitor
- Observational
- Registry
- Abatacept / adverse effects
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents / adverse effects
- Arthritis, Rheumatoid / chemically induced
- Arthritis, Rheumatoid / drug therapy
- Glucocorticoids / adverse effects
- Humans
- Tumor Necrosis Factor Inhibitors / therapeutic use
- Abatacept
- Glucocorticoids
- Antirheumatic Agents
- Tocilizumab
- Tumor Necrosis Factor Inhibitors
Affiliation entities
Citation (ISO format)
LAUPER, Kim et al. Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies. In: Joint bone spine, 2024, vol. 91, n° 2, p. 105671. doi: 10.1016/j.jbspin.2023.105671
Main files (1)
Article (Published version)
Secondary files (2)
Identifiers
- PID : unige:178521
- DOI : 10.1016/j.jbspin.2023.105671
- PMID : 38042363
Additional URL for this publicationhttps://linkinghub.elsevier.com/retrieve/pii/S1297319X23001501
Journal ISSN1297-319X